Dermata Therapeutics, Inc. Common Stock DRMA
$0.57
-4.75%
at last close
Analyst Consensus
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2025-08-21 | Maxim GroupAnthony Vendetti |
Maintains | Buy | $30 → $10 |
| 2025-05-21 | Maxim GroupAnthony Vendetti |
Maintains | Buy | $6 → $3 |
| 2024-08-21 | Maxim GroupAnthony Vendetti |
Maintains | Buy | $10 → $6 |
| 2023-03-23 | Maxim GroupAnthony Vendetti |
Maintains | Buy | $240 → $60 |
| 2021-09-21 | Brookline CapitalKumaraguru Raja |
Initiates coverage on | Buy | $3360 |
| 2021-09-14 | Maxim GroupAnthony Vendetti |
Initiates coverage on | Buy | $2160 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $0.57
- Market Cap
- $2.95 million
- 52-Week Range
- $0.57 – $4.66
- Average Volume
- 5.89 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.
